CEAMSA: A Key Partner in the Formulation of High-Quality Plant-Based Capsules

The demand for vegan and naturally sourced products continues to grow, especially in the dietary supplement and pharmaceutical markets. For manufacturers aiming to offer 100% plant-based capsules without compromising on quality, CEAMSA’s carefully selected extracts stand out for their functionality and plant-based origin.

With our extensive experience in developing solutions for all types of plant-based capsules—both soft and hard—our hydrocolloids have demonstrated excellent mechanical properties, strong stability, and widely recognized quality.

Why choose our solutions for capsule manufacturing?

  • Transparency and shine
  • Thermal resistance
  • Biodegradable
  • Non-allergenic
  • Suitable for vegetarians, vegans & religious dietary restrictions
  • USP/EU pharmacopoeia quality

Looking for a tailored plant-based solution?

At CEAMSA, we work closely with manufacturers to deliver the solution that best fits their specific needs.

Latest news

3Jul 2025

CEAMSA publishes its 2024 Sustainability Report highlighting significant progress across its strategic pillars

The company advances on its “Purely Sustainable” roadmap and reaffirms its commitment to a responsible, transparent industry aligned with the Sustainable Development Goals (SDGs). CEAMSA has published its 2024 Non-Financial Information Statement (EINF), a document that reflects the company’s sustainability progress over the past year and consolidates the results of its “Purely Sustainable” strategy, presented

27Jun 2025

CEAMSA Showcases Progress in Innovation and Sustainable Technologies at the Atlantic Bioprocessing Summit 2025

On June 17th, CEAMSA took part in the Atlantic Bioprocessing Summit 2025, organized by the Life Sciences Cluster of Galicia (Bioga) and held in Santiago de Compostela. The company shared with the biotechnology innovation ecosystem the latest progress in its initiatives in the fields of foodtech and industrial sustainability, presenting updates on two of its